Neurocrine Biosciences (NBIX) Tops Q1 EPS by 28c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Wall St set for higher open after Micron revives AI optimism, upbeat economic data
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
Neurocrine Bio. (NBIX) PT Lowered to $122 at Canaccord Genuity
May 5, 2020 8:01 AM EDTCanaccord Genuity analyst Sumant Kulkarni lowered the price target on Neurocrine Bio. (NASDAQ: NBIX) to $122.00 (from $127.00) while maintaining a Buy rating.... More
